
- January 2019
- Volume 4
- Issue 1
FDA Approves New Products
The FDA has approved two new products, one for feline parasite protection and the other for canine noise aversion.
REVOLUTION PLUS (SELAMECTIN AND SAROLANER TOPICAL SOLUTION; ZOETIS)
The 6-in-1 feline parasite preventive protects against fleas (Ctenocephalides felis), ticks (black-legged or deer ticks [Ixodes scapularis], Gulf Coast ticks [Amblyomma maculatum], and American dog ticks [Dermacentor vari­abilis]), ear mites (Otodectes cynotis), roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme), and heartworms (Dirofilaria immitis). The product can be used in cats and kittens as young as 8 weeks that weigh at least 2.8 lb.
PEXION (IMEPITOIN TABLETS; BOEHRINGER INGELHEIM)
Approved for the treatment of noise aversion in dogs, Pexion is dosed (according to weight) twice daily starting 2 days before an expected noise event and continued through the day of the event. The medication will be provided in 100- and 400-mg scored tablets. Due to “capacity constraints at the manufacturing site," however, Pexion will likely not be available for sale until 2020, according to a Boehringer-Ingelheim spokesperson.
Articles in this issue
over 6 years ago
Advice Unleashed (January 2019)over 6 years ago
Clinical Tidbits (January 2019)over 6 years ago
EIA Is Confirmed in Multiple Texas Countiesover 6 years ago
USDA Grants $2.4 Million to Address Rural Veterinarian Shortageover 6 years ago
Dogs Dominate in US Homes, But Exotics Are Gaining Groundover 6 years ago
2019 Pet Care Trends Focus on Techover 6 years ago
AAFP Releases Consensus Statement on Feline Feedingover 6 years ago
Finnish Scientists Develop First Insect Vaccineover 6 years ago
Addressing an Animal Welfare Crisisalmost 7 years ago
What's New With Cushings DiseaseNewsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.